Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

Kilroy Realty Corporation has locked in another life sciences tenant for its Oyster Point project in South San Francisco. San ...

Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...

Health Biotech Limited, an Indian pharmaceutical company, successfully showcased its innovative products at CPHI Frankfurt 2025, a notable global pharmaceutical event. The company, celebrated for its ...

4D said it will receive an $85 million upfront cash payment from Otsuka and expects to receive at least $50 million of cost sharing from its partner over the next three years for development ...

Alnylam and Neurocrine shares tumbled despite upbeat sales reports. Elsewhere, Biogen is dealing with what one analyst called ...

Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps Pfizer’s agreed bid made in September, which valued New ...

Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...